Email this article 
Gemcitabine-Related Acute Coronary Syndrome
Abstract
A strong association of gemcitabine to acute coronary syndrome (ACS) is not currently established in the literature. In this series, we highlight that both patients with gemcitabine-related ACS were more than 50 years old, had underlying coronary artery disease and suffered from metastatic cancer. However, further prospective studies are required to validate the significance of these observations.
J Med Cases. 2020;11(1):30-33
doi: https://doi.org/10.14740/jmc3417
J Med Cases. 2020;11(1):30-33
doi: https://doi.org/10.14740/jmc3417
Keywords
Gemcitabine; Cardiotoxicity; Acute coronary syndrome